Dover Advisors LLC purchased a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund purchased 7,378 shares of the financial services provider’s stock, valued at approximately $1,369,000.
Other hedge funds have also recently modified their holdings of the company. Numerai GP LLC raised its position in shares of Marsh & McLennan Companies by 966.2% during the 3rd quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after purchasing an additional 33,729 shares during the last quarter. Swiss Life Asset Management Ltd raised its position in shares of Marsh & McLennan Companies by 9.5% during the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after purchasing an additional 11,648 shares during the last quarter. Rockland Trust Co. raised its position in shares of Marsh & McLennan Companies by 801.6% during the 3rd quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider’s stock worth $2,433,000 after purchasing an additional 10,734 shares during the last quarter. Barclays PLC raised its position in shares of Marsh & McLennan Companies by 41.7% during the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock worth $443,844,000 after purchasing an additional 647,987 shares during the last quarter. Finally, Sarasin & Partners LLP raised its position in shares of Marsh & McLennan Companies by 0.9% during the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock worth $173,411,000 after purchasing an additional 8,283 shares during the last quarter. Institutional investors and hedge funds own 87.99% of the company’s stock.
Marsh & McLennan Companies Stock Down 0.6%
Shares of NYSE MRSH opened at $161.65 on Wednesday. Marsh & McLennan Companies, Inc. has a 12-month low of $157.74 and a 12-month high of $235.78. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. The stock has a market cap of $78.09 billion, a P/E ratio of 20.21, a price-to-earnings-growth ratio of 2.37 and a beta of 0.62.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on the stock. Morgan Stanley reduced their price target on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a research report on Monday, April 6th. Barclays dropped their price objective on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. Bank of America dropped their price objective on shares of Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a research note on Tuesday, April 14th. Weiss Ratings cut shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Finally, Piper Sandler dropped their price objective on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $203.56.
Read Our Latest Analysis on Marsh & McLennan Companies
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Stories
- Five stocks we like better than Marsh & McLennan Companies
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear CaseāIs a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
